Skip to content
  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
  • English
  • French
PHP Toggle Menu

Category: Press release

Agreement with FDA Announced for Special Protocol Assessment for Upcoming Phase 3 Pexa-Vec Trial in Advanced Liver Cancer

20150416 SPA release version EN clean

Published 16 April 2015
Categorized as 2015, Pexa-Vec, Press release

Transgene Reports 2014 Financial Results and Outlines Promising Clinical Pipeline (webcast)

20150324 FY results 2014 full release_ENG FINAL

Published 24 March 2015
Categorized as 2015, Press release

Transgene Announces New Pre-Clinical Data with TG4010 in Combination with Immune Checkpoint Inhibitors and TG3003 (humanized mAb anti-CD115) to be Presented at AACR

18032015_AACR 2015 curtain raiser_EN

Published 19 March 2015
Categorized as 2015, Press release, TG3003, TG4010

Transgene Announces Financial Calendar for 2015

20150107 PR 2015 financial calendar_EN_ver 1

Published 8 January 2015
Categorized as 2015, Press release

Transgene Announces Third Quarter 2014 Financial Results

266_en

Published 21 October 2014
Categorized as 2014, Press release

Transgene Reports Financial Results for First Six Months of 2014 and Provides Update on TG4010

261_en

Published 8 September 2014
Categorized as 2014, Press release, TG4010

Transgene Reports First Quarter 2014 Financial Results

254_en

Published 22 April 2014
Categorized as 2014, Press release

Transgene Reports Fiscal Year 2013 Results and Provides Business Update

253_en

Published 26 March 2014
Categorized as 2014, Press release

Posts pagination

Newer posts Page 1 … Page 33
Get to know us

About us

myvac

Pipeline

Investors

Partnering

Company

Career

ESG

Suppliers

Contacts

Legal documents

Legal notices

Privacy Policy

Ethics and compliance

Cookie policy

  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
  • English
  • French
Menu